Takeda Consumer Healthcare Co. Ltd.
www.takeda.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Takeda Consumer Healthcare Co. Ltd.
Schizophrenia, Depression And Neuropathy: What’s Coming In 2024
The following four neurological products are likely to reach market next year. Carving out sales will be an entirely different problem.
APAC Life Sciences Valuation Trends: Chinese Firms Eclipse Japan, India Peers
Chinese healthcare and life sciences firms now overshadow their peers in Japan and India in terms of key valuation metrics amid COVID-19 and China has also witnessed significant M&A activity at high revenue multiples.
Takeda Expects Stronger Net Profit On Lower Tax
Entyvio strong again for Japanese firm as it raises net profit forecast on lower tax costs. Meanwhile, 'Wave 1' pipeline projects are progressing, with simultaneous development in major markets a key goal.
Another Divestment By Takeda, To China’s Hasten For $322m
Japanese major sheds further non-core assets as it continues to focus on innovation and pay down debt following the Shire acquisition.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice